Wall Street Zen downgraded shares of Dolby Laboratories (NYSE:DLB – Free Report) from a buy rating to a hold rating in a research report sent to investors on Saturday morning.
Other equities analysts have also issued reports about the company. Baird R W raised Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Rosenblatt Securities dropped their price objective on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating on the stock in a report on Wednesday, November 19th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a report on Thursday, November 13th. Barrington Research decreased their price target on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 19th. Finally, Tigress Financial raised their price objective on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a research report on Friday, August 15th. Three equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $92.00.
Get Our Latest Research Report on DLB
Dolby Laboratories Stock Performance
Dolby Laboratories (NYSE:DLB – Get Free Report) last posted its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share for the quarter, topping the consensus estimate of $0.70 by $0.29. The firm had revenue of $307.02 million during the quarter, compared to the consensus estimate of $305.76 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The company’s revenue was up .7% on a year-over-year basis. During the same quarter last year, the company earned $0.61 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS. Q1 2026 guidance at 0.790-0.940 EPS. Equities research analysts forecast that Dolby Laboratories will post 2.94 EPS for the current fiscal year.
Dolby Laboratories Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd will be paid a $0.36 dividend. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Tuesday, December 2nd. Dolby Laboratories’s payout ratio is 54.75%.
Insider Buying and Selling at Dolby Laboratories
In other Dolby Laboratories news, SVP Shriram Revankar sold 3,000 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $65.55, for a total value of $196,650.00. Following the completion of the transaction, the senior vice president owned 67,435 shares of the company’s stock, valued at $4,420,364.25. The trade was a 4.26% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP John D. Couling sold 6,164 shares of the firm’s stock in a transaction on Thursday, November 20th. The shares were sold at an average price of $66.12, for a total transaction of $407,563.68. Following the sale, the senior vice president owned 115,338 shares in the company, valued at approximately $7,626,148.56. This trade represents a 5.07% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 59,164 shares of company stock worth $4,117,464 over the last three months. 38.39% of the stock is owned by insiders.
Institutional Investors Weigh In On Dolby Laboratories
Hedge funds have recently added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Dolby Laboratories during the 2nd quarter valued at about $55,030,000. AQR Capital Management LLC grew its position in Dolby Laboratories by 51.8% during the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after acquiring an additional 592,282 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Dolby Laboratories by 7.1% during the first quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker’s stock worth $605,194,000 after acquiring an additional 502,110 shares in the last quarter. Jones Financial Companies Lllp lifted its holdings in shares of Dolby Laboratories by 241,160.1% in the 1st quarter. Jones Financial Companies Lllp now owns 429,443 shares of the electronics maker’s stock worth $36,975,000 after acquiring an additional 429,265 shares during the last quarter. Finally, First Trust Advisors LP lifted its holdings in shares of Dolby Laboratories by 35.2% in the 2nd quarter. First Trust Advisors LP now owns 1,237,443 shares of the electronics maker’s stock worth $91,893,000 after acquiring an additional 322,063 shares during the last quarter. Institutional investors own 58.56% of the company’s stock.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Recommended Stories
- Five stocks we like better than Dolby Laboratories
- What Are Dividend Challengers?
- D-Wave: Time to Buy the Dip? Or is the Fall Just Starting?
- How to Read Stock Charts for Beginners
- Hims, Block, and NRG Just Launched Huge Stock Buybacks
- The Basics of Support and Resistance
- Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
